Sat, Dec 20, 2014, 6:58 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • adspatz adspatz Jul 30, 2013 10:23 AM Flag

    Pfizer quarterly earnings drop 10%

    Search for "SEC Live Filings Digest" to find out more.
    Pfizer (PFE) announced its second quarter financial results, reporting a revenue decrease of 7% to $12.97B. The company’s earnings decreased 10%, from $4.45B a year ago this quarter to now $4.00B. Earnings per share fell $0.03 from $0.59 per share to $0.56 per share. Pfizer’s revenue of $12.97B fell just short of the $13.02B expected by analysts, with the 7% decrease credited to a 4% decline in operations and a 3% impact from foreign exchange rates. Pfizer, along with other pharmaceutical companies, is trying to steer its business away from slow-growth operations. The company plans to separate its commercial operations into three business units and analysts are hoping the company will also spin-off its generics business, though that is unlikely before 2016. CEO Ian Read remarked that the company is positioning itself for long-term success and reaffirmed the annual earnings forecast of $2.10 to $2.20 earnings per share.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
31.94-0.03(-0.09%)Dec 19 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.